QBIO News and Press, Q BioMed Inc From 03/07/22

Q BioMed Announces Initial $500k Order of Strontium89 to Chinese Market Order Represents a small fraction of the overall market PR Newswire NEW YORK , March 7, 2022 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced...

Q BioMed Outlines Strategic Direction for 2022 Revenue Grows, Monetization Focus PR Newswire NEW YORK , Feb. 14, 2022 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a biomedical acceleration and development company, focused on licensing, acquiring,...

Q BioMed Shows Significant Uptrend in Revenues in Year-End Update Revenue up 600% in 2021 and 100% in Q4 Nasdaq Listing Expected in Jan 2022 PR Newswire NEW YORK , Dec. 16, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO ), a commercia...

Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership Fully integrated commercialization model and newly appointed leadership to accelerate U.S. business PR Newswire NEW YORK and CHICAGO, Nov. 8, 2021 /PRNewswire/ -- Q BioMed I...

Q BioMed Inc. Provides Shareholder Update $2M Raised with focus on sales and licensing revenue pipeline and Uplisting to Nasdaq PR Newswire NEW YORK , Oct. 25, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a biotech acceleration and comm...

Q BioMed Inc. Provides Update on Strontium89 Commercial Roll Out Revenue Up in 4th Quarter with Positive Trend PR Newswire NEW YORK , Sept. 28, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO ) a biotech acceleration and commercial stage company focus...

Palm Beach, FL – September 22, 2021 – FinancialNewsMedia.com News Commentary – The U.S. government, via the American Rescue Plan, is investing more than $3 billion to accelerate the discovery, development and manufacturing of antiviral medicines as part of t...

Q BioMed Inc. Updates on COVID-19 Therapeutic Development and Clinical Trials - MAN-19 therapeutic program heading to clinical trial in early 2022 PR Newswire NEW YORK , Sept. 22, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a commercial sta...

Palm Beach, FL – August 24, 2021 – FinancialNewsMedia.com News Commentary – Recently, approximately 1.2 million new liver cancer cases have been reporting around the world. The increasing intense research and development activities opposing dangerous disease...

Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent in South Korea and Shows Promising Results in Initial Pre-Clinical Testing PR Newswire NEW YORK , Aug. 24, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech ...